Tumor-directed PET imaging of bone metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled anti-prostate specific membrane antigen (PSMA) antibody J591.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael J. Morris, Neeta Pandit-Taskar, Scott T. Tagawa, David M. Nanus, Stephen Barnett Solomon, Jorge A. Carrasquillo, Victor E. Reuter, Jason Stuart Lewis, Volkan Beylergil, Joseph A. O' Donoghue, Serge K. Lyashchenko, Danny F. Martinez, Kristen Rebecca Curtis, Jeremy C. Durack, Sarah M. Cheal, Neil Harrison Bander, Howard I. Scher, Steven M. Larson
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2208957248
